Understanding Herpes Simplex Virus Type 1 Versus Herpes Simplex Virus Type 2 Encephalitis After Neurosurgery: A Case Series and Literature Review
- PMID: 37527427
- DOI: 10.1089/sur.2023.030
Understanding Herpes Simplex Virus Type 1 Versus Herpes Simplex Virus Type 2 Encephalitis After Neurosurgery: A Case Series and Literature Review
Abstract
Abstract Background: Herpes simplex virus encephalitis (HSVE) is a rare post-operative infection that can be fatal if treatment is delayed. Herpes simplex virus type 1 (HSV-1) is a more common cause of encephalitis than herpes simplex virus type 2 (HSV-2), however, a significant overlap exists. The goal of this project was to understand the frequency and trend of HSVE after neurosurgery through a case series at our institution and in the literature with a focus on comparing HSV-1 versus HSV-2. Patients and Methods: A literature review of all published cases and case series of HSVE after neurosurgery was performed. Descriptive statistics comparing HSV-1 and HSV-2 encephalitis were computed. Data on demographics, symptoms, surgery, treatment, immunosuppression, imaging findings, steroids, and mortality were collected. Results: We identified 55 total cases of HSVE post-neurosurgery. These included 28 cases of HSV-1, 10 cases of HSV-2, and 17 cases of HSV-unspecified encephalitis. There were no differences in age, gender, symptoms, surgery, or latency between surgery and symptom onset between HSV-1 and HSV-2. Mortality was higher with HSV-1 versus HSV-2 although not statistically significant. The primary surgical indication varied substantially between HSV-1 and HSV-2. Conclusions: Herpes simplex virus encephalitis is often overlooked in the setting of encephalitis after surgery. A high index of suspicion is needed to prevent a delay in treatment.
Keywords: HSVE; herpes simplex; herpes simplex virus encephalitis; neurosurgery.
Similar articles
-
Clinical signs as a guide for performing HSV-PCR in correct diagnosis of herpes simplex virus encephalitis.Neurol India. 2003 Sep;51(3):341-4. Neurol India. 2003. PMID: 14652434 Clinical Trial.
-
Herpes simplex reactivation following neurosurgery: case report and review of the literature.Neurosurg Focus. 2019 Aug 1;47(2):E9. doi: 10.3171/2019.5.FOCUS19281. Neurosurg Focus. 2019. PMID: 31370030 Review.
-
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF.Neurology. 1998 Aug;51(2):554-9. doi: 10.1212/wnl.51.2.554. Neurology. 1998. PMID: 9710034
-
Herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult population with aseptic meningitis or encephalitis: A nine-year retrospective clinical study.Medicine (Baltimore). 2021 Nov 19;100(46):e27856. doi: 10.1097/MD.0000000000027856. Medicine (Baltimore). 2021. PMID: 34797322 Free PMC article.
-
Distinguishing Features Common to Dual Fatal Herpes Simplex Virus Infections That Occur in Both a Pregnant Woman and Her Newborn Infant.Viruses. 2021 Dec 18;13(12):2542. doi: 10.3390/v13122542. Viruses. 2021. PMID: 34960811 Free PMC article. Review.
Cited by
-
Clinic-radiological classification of herpesviral encephalitis in humans (systematic review).J Neurovirol. 2025 Jun;31(3):219-241. doi: 10.1007/s13365-025-01250-1. Epub 2025 Apr 19. J Neurovirol. 2025. PMID: 40253477 Review.
-
A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 Infection in Mice.Vaccines (Basel). 2025 May 6;13(5):497. doi: 10.3390/vaccines13050497. Vaccines (Basel). 2025. PMID: 40432109 Free PMC article.
-
A viral attack on brain tumors: the potential of oncolytic virus therapy.J Neurovirol. 2024 Jun;30(3):229-250. doi: 10.1007/s13365-024-01209-8. Epub 2024 May 28. J Neurovirol. 2024. PMID: 38806994 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical